Michelle M. Lebeau to Male
This is a "connection" page, showing publications Michelle M. Lebeau has written about Male.
Connection Strength
0.111
-
Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms. Blood. 2015 Dec 24; 126(26):2899-901.
Score: 0.028
-
Overexpression and knockout of miR-126 both promote leukemogenesis. Blood. 2015 Oct 22; 126(17):2005-15.
Score: 0.028
-
Cohort profile: the ChicagO Multiethnic Prevention and Surveillance Study (COMPASS). BMJ Open. 2020 09 16; 10(9):e038481.
Score: 0.010
-
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2017 04; 58(4):950-958.
Score: 0.008
-
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes. Proc Natl Acad Sci U S A. 2015 Nov 17; 112(46):E6359-68.
Score: 0.007
-
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014 Aug 14; 512(7513):198-202.
Score: 0.006
-
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Cancer Res. 2005 Dec 15; 65(24):11565-71.
Score: 0.004
-
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet. 2000 May 22; 9(9):1425-32.
Score: 0.002
-
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia. 2000 Jan; 14(1):216-8.
Score: 0.002
-
Expression and cytogenetic localization of the human SM22 gene (TAGLN). Genomics. 1998 May 01; 49(3):452-7.
Score: 0.002
-
Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate. 1997 Dec 01; 33(4):271-80.
Score: 0.002
-
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997 Mar 15; 89(6):2079-88.
Score: 0.002
-
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes Chromosomes Cancer. 1996 Apr; 15(4):206-16.
Score: 0.002
-
Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes. 1994 Mar; 43(3):389-95.
Score: 0.002
-
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood. 1993 Nov 15; 82(10):2975-84.
Score: 0.002
-
Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia. Leukemia. 1993 Nov; 7(11):1865-74.
Score: 0.002
-
Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood. 1993 May 15; 81(10):2728-34.
Score: 0.001
-
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood. 1993 Feb 15; 81(4):883-8.
Score: 0.001
-
Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A. 1991 Dec 01; 88(23):10735-9.
Score: 0.001